Uromodulin-related autosomal-dominant tubulointerstitial kidney disease—pathogenetic insights based on a case

Abstract Uromodulin-related autosomal-dominant tubulointerstitial kidney disease (ADTKD-UMOD) is a rare monogenic disorder that is characterized by tubulointerstitial fibrosis and progression of kidney function loss, and may progress to end-stage renal disease. It is usually accompanied by hyperuricaemia and gout. Mutations in the uromodulin gene (UMOD) resulting in malfunctioning of UMOD are known to be the cause of ADTKD-UMOD, which is assumed to be an endoplasmatic reticulum (ER) storage disease. As a case vignette, we report a 29-year-old female with a suspicious family history of chronic kidney disease presenting with progressive loss of renal function, hyperuricaemia and frequent urinary tract infections. Urinary tract infections and pyelonephritides may represent a clinical feature of uromodulin malfunction as it plays a protective role against urinary tract infections despite only sporadic data on this topic. ADTKD-UMOD was diagnosed after genetic testing revealing a missense mutation in the UMOD gene. Light microscopy showed excessive tubular interstitial fibrosis and tubular atrophy together with signs of glomerular sclerosis. Electron microscopic findings could identify electron dense storage deposits in the ER of tubular epithelial cells of the thick ascending loop. Immunohistological staining with KDEL (lysine, aspartic acid, glutamic acid, leucine) showed positivity in the tubular cells, which likely represents ER expansion upon accumulation of misfolded UMOD which could trigger the unfolded protein response and ER stress. This review highlights pathophysiological mechanisms that are subject to ADTKD-UMOD.

[1]  J. Lieske,et al.  Tamm-Horsfall protein/uromodulin deficiency elicits tubular compensatory responses leading to hypertension and hyperuricemia. , 2018, American journal of physiology. Renal physiology.

[2]  G. Walters,et al.  Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease. , 2017, The Cochrane database of systematic reviews.

[3]  O. Devuyst,et al.  Uromodulin: from physiology to rare and complex kidney disorders , 2017, Nature Reviews Nephrology.

[4]  M. Rastaldi,et al.  Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutations , 2017, Scientific Reports.

[5]  T. Bartz,et al.  Urinary Uromodulin and Risk of Urinary Tract Infections: The Cardiovascular Health Study. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  E. Ars,et al.  A review on autosomal dominant tubulointerstitial kidney disease. , 2017 .

[7]  S. Kmoch,et al.  Autosomal Dominant Tubulointerstitial Kidney Disease. , 2017, Advances in chronic kidney disease.

[8]  R. Wanke,et al.  Mitochondrial Dysregulation Secondary to Endoplasmic Reticulum Stress in Autosomal Dominant Tubulointerstitial Kidney Disease – UMOD (ADTKD-UMOD) , 2017, Scientific Reports.

[9]  A. Halankar,et al.  Uromodulin Levels in Chronic Kidney Disease , 2016 .

[10]  A. Hoischen,et al.  Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia , 2016, American journal of human genetics.

[11]  S. Kmoch,et al.  Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related , 2016 .

[12]  M. Nagel,et al.  Autosomal dominant tubulointerstitial kidney disease caused by uromodulin mutations: seek and you will find , 2016, Wiener klinische Wochenschrift.

[13]  T. Onoe,et al.  Hints to the diagnosis of uromodulin kidney disease , 2015, Clinical kidney journal.

[14]  O. Devuyst,et al.  The serine protease hepsin mediates urinary secretion and polymerisation of Zona Pellucida domain protein uromodulin , 2015, eLife.

[15]  S. Sharma,et al.  Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia , 2015, Journal of Investigative Medicine.

[16]  K. Dahan,et al.  Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report. , 2015, Kidney international.

[17]  D. Blondin,et al.  Smaller caliber renal arteries are a novel feature of uromodulin-associated kidney disease. , 2015, Kidney international.

[18]  M. Goicoechea,et al.  Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  K. Dahan,et al.  Paradoxical response to furosemide in uromodulin-associated kidney disease. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  M. Uder,et al.  Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin. , 2014, Kidney international.

[21]  S. Kmoch,et al.  Autosomal dominant tubulointerstitial kidney disease: of names and genes. , 2014, Kidney international.

[22]  Su-xia Wang,et al.  Novel UMOD mutations in familial juvenile hyperuricemic nephropathy lead to abnormal uromodulin intracellular trafficking. , 2013, Gene.

[23]  Thomas M. Kitzler,et al.  Association between genotype and phenotype in uromodulin-associated kidney disease. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[24]  Eric S. Lander,et al.  Mutations causing medullary cystic kidney disease type 1 (MCKD1) lie in a large VNTR in MUC1 missed by massively parallel sequencing , 2013, Nature Genetics.

[25]  Michael T. McManus,et al.  IRE1α Cleaves Select microRNAs During ER Stress to Derepress Translation of Proapoptotic Caspase-2 , 2012, Science.

[26]  Peter J. Belmont,et al.  Protein disulfide isomerase-associated 6 is an ATF6-inducible ER stress response protein that protects cardiac myocytes from ischemia/reperfusion-mediated cell death. , 2012, Journal of molecular and cellular cardiology.

[27]  Sian E. Piret,et al.  Epidemiology of Uromodulin-Associated Kidney Disease – Results from a Nation-Wide Survey , 2012, Nephron Extra.

[28]  T. Gibson Hyperuricemia, gout and the kidney , 2012, Current opinion in rheumatology.

[29]  M. Lipkowitz Regulation of Uric Acid Excretion by the Kidney , 2012, Current Rheumatology Reports.

[30]  K. Dahan,et al.  Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[31]  Peter Walter,et al.  Unfolded Proteins Are Ire1-Activating Ligands That Directly Induce the Unfolded Protein Response , 2011, Science.

[32]  P. Persson,et al.  Activation of the Bumetanide-sensitive Na+,K+,2Cl− Cotransporter (NKCC2) Is Facilitated by Tamm-Horsfall Protein in a Chloride-sensitive Manner* , 2011, The Journal of Biological Chemistry.

[33]  M. Ward,et al.  Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein , 2011, Urological Research.

[34]  S. Kmoch,et al.  Uromodulin Biology and Pathophysiology – An Update , 2010, Kidney and Blood Pressure Research.

[35]  S. Waldegger,et al.  Tamm-Horsfall Glycoprotein Interacts with Renal Outer Medullary Potassium Channel ROMK2 and Regulates Its Function* , 2010, The Journal of Biological Chemistry.

[36]  A. Evan,et al.  Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein. , 2010, American journal of physiology. Renal physiology.

[37]  P. Jennings,et al.  Evidence for a role of uromodulin in chronic kidney disease progression. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[38]  Michele Sallese,et al.  The KDEL receptor: New functions for an old protein , 2009, FEBS letters.

[39]  P. Rorsman,et al.  Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum. , 2009, Human molecular genetics.

[40]  C. Antignac,et al.  Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. , 2009, American journal of human genetics.

[41]  J. Bates,et al.  Tamm-horsfall protein protects against urinary tract infection by proteus mirabilis. , 2009, The Journal of urology.

[42]  I. Hisatome,et al.  Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients. , 2008, American journal of hypertension.

[43]  A. Bachi,et al.  Urinary uromodulin carries an intact ZP domain generated by a conserved C-terminal proteolytic cleavage. , 2008, Biochemical and biophysical research communications.

[44]  V. D’Agati,et al.  Uromodulin storage disease. , 2008, Kidney international.

[45]  Y. Pirson,et al.  Outcome of kidney transplantation in familial juvenile hyperuricaemic nephropathy. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  F. Hildebrandt,et al.  The Uromodulin C744G mutation causes MCKD2 and FJHN in children and adults and may be due to a possible founder effect. , 2007, Kidney international.

[47]  F. Scolari,et al.  Defective Intracellular Trafficking of Uromodulin Mutant Isoforms , 2006, Traffic.

[48]  Z. Laszik,et al.  Tamm-Horsfall Protein Acts as a General Host-Defense Factor against Bacterial Cystitis , 2005, American Journal of Nephrology.

[49]  T. Hart,et al.  Mutant tamm-horsfall glycoprotein accumulation in endoplasmic reticulum induces apoptosis reversed by colchicine and sodium 4-phenylbutyrate. , 2005, Journal of the American Society of Nephrology : JASN.

[50]  F. Scolari,et al.  Uromodulin storage diseases: clinical aspects and mechanisms. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[51]  J. Alan Diehl,et al.  PERK-dependent Activation of Nrf2 Contributes to Redox Homeostasis and Cell Survival following Endoplasmic Reticulum Stress* , 2004, Journal of Biological Chemistry.

[52]  Hong-ying Huang,et al.  Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. , 2004, American journal of physiology. Renal physiology.

[53]  S. Hultgren,et al.  Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. , 2004, Kidney international.

[54]  F. Scolari,et al.  Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. , 2003, Human molecular genetics.

[55]  D. Vertommen,et al.  A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. , 2003, Journal of the American Society of Nephrology : JASN.

[56]  D. Cavallone,et al.  Tamm-Horsfall glycoprotein: biology and clinical relevance. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[57]  Y. Kohno,et al.  The KDEL Receptor Modulates the Endoplasmic Reticulum Stress Response through Mitogen-activated Protein Kinase Signaling Cascades* , 2003, Journal of Biological Chemistry.

[58]  A. Hattersley,et al.  Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1beta gene mutation. , 2003, Kidney international.

[59]  N. Borgese,et al.  KDEL and KKXX retrieval signals appended to the same reporter protein determine different trafficking between endoplasmic reticulum, intermediate compartment, and Golgi complex. , 2003, Molecular biology of the cell.

[60]  T C Hart,et al.  Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy , 2002, Journal of medical genetics.

[61]  B. Goud,et al.  Localization of the Lys, Asp, Glu, Leu tetrapeptide receptor to the Golgi complex and the intermediate compartment in mammalian cells , 1994, The Journal of cell biology.

[62]  P. Jennings,et al.  Membrane targeting and secretion of mutant uromodulin in familial juvenile hyperuricemic nephropathy. , 2007, Journal of the American Society of Nephrology : JASN.

[63]  J. Kamerling,et al.  Glycosylation sites and site-specific glycosylation in human Tamm-Horsfall glycoprotein. , 1999, Glycobiology.